FAQs

Biosimilars Global Market Report 2022 – By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Types (Human Growth Hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor), By Application (Oncology, Chronic and Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases) – Market Size, Trends, And Global Forecast 2022-2026

What is the definition of the biosimilars market?

The biosimilars market consists of sales of biosimilars and related services that are used to treat chronic diseases such as diabetes, arthritis, and cancer. Biosimilars are pharmaceuticals that are manufactured using cell lines and offer no clinical difference as compared to biologics. Biosimilars are made once the patent of biologics is expired.

How will the biosimilars market drivers and restraints affect biosimilars market dynamics? What forces will shape the biosimilars industry going forward?

The biosimilars market growth is aided by rising prevalence of chronic diseases. However, some biosimilars market restraints include lack of awareness about biosimilars among primary care physicians (PCPs) and specialists

What is the forecast market size of the biosimilars market?

The biosimilars market forecast is expected to reach $21.13 billion in 2025 at a compound annual growth rate of 27%.

How is the biosimilars market segmented?

The global biosimilars market is segmented -
1) By Product: Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins
2) By Types: Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Others
3) By Application: Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Others

Which region has largest share, and what is the market size and growth by geography according to the biosimilars global market report?

For more detail on this, request a sample here.

Who are the key players of the global biosimilars market?

Top competitors in the biosimilars market are Pfizer, Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Boehringer Ingelheim, Elli Lilly and Company, Mylan N.V., Sanofi, and STADA Arzneimittel

What are the key trends in the global biosimilars market?

Major trends influencing the biosimilars market include production of new insulin biosimilars

What are the major opportunities in the biosimilars market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global biosimilars market, request a sample here

How does the biosimilars market relate to the overall economy and other similar markets?

For this and further detailed insights on the market, request a sample here.